Heidelberg Pharma AG Statistics

Total Valuation

FRA:HPHA has a market cap or net worth of EUR 199.47 million. The enterprise value is 166.34 million.

Market Cap	199.47M
Enterprise Value	166.34M

Important Dates

The next estimated earnings date is Friday, October 10, 2025.

Earnings Date	Oct 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	46.60M
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+4.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47.68
PB Ratio	10.77
P/TBV Ratio	20.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.14
EV / Sales	39.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.11

Financial Position

The company has a current ratio of 7.74, with a Debt / Equity ratio of 0.01.

Current Ratio	7.74
Quick Ratio	5.64
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-5,400.11

Financial Efficiency

Return on equity (ROE) is -78.11% and return on invested capital (ROIC) is -56.21%.

Return on Equity (ROE)	-78.11%
Return on Assets (ROA)	-25.08%
Return on Invested Capital (ROIC)	-56.21%
Return on Capital Employed (ROCE)	-48.08%
Revenue Per Employee	37,687
Profits Per Employee	-209,980
Employee Count	105
Asset Turnover	0.06
Inventory Turnover	0.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.59% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+79.59%
50-Day Moving Average	4.38
200-Day Moving Average	3.09
Relative Strength Index (RSI)	49.04
Average Volume (20 Days)	17,252

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:HPHA had revenue of EUR 4.18 million and -23.31 million in losses. Loss per share was -0.50.

Revenue	4.18M
Gross Profit	3.66M
Operating Income	-26.97M
Pretax Income	-23.31M
Net Income	-23.31M
EBITDA	-26.24M
EBIT	-26.97M
Loss Per Share	-0.50

Full Income Statement

Balance Sheet

The company has 33.25 million in cash and 122,226 in debt, giving a net cash position of 33.13 million.

Cash & Cash Equivalents	33.25M
Total Debt	122,226
Net Cash	33.13M
Net Cash Per Share	n/a
Equity (Book Value)	18.52M
Book Value Per Share	0.40
Working Capital	42.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -26.78 million and capital expenditures -450,656, giving a free cash flow of -27.23 million.

Operating Cash Flow	-26.78M
Capital Expenditures	-450,656
Free Cash Flow	-27.23M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	87.55%
Operating Margin	-644.66%
Pretax Margin	-557.16%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:HPHA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	n/a
Earnings Yield	-11.68%
FCF Yield	-13.65%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

FRA:HPHA has an Altman Z-Score of -6.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.59
Piotroski F-Score	2